Precipio (PRPO) News Today → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free PRPO Stock Alerts $5.68 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrecipio Secures a short-term $500K Credit Facilityglobenewswire.com - May 6 at 5:00 PMPrecipio, Inc. (PRPO) Latest Stock News & Headlines - Yahoo Financefinance.yahoo.com - April 20 at 10:44 PMPrecipio Inc PRPOmorningstar.com - April 19 at 4:06 PMPrecipio Announces Year end 2023 Shareholder Update Callglobenewswire.com - March 25 at 5:00 PMPrecipio, Inc. (PRPO)ca.finance.yahoo.com - March 12 at 9:50 AMPrecipio Stock (NASDAQ:PRPO), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 23 at 5:33 AMPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoYfinance.yahoo.com - February 13 at 5:30 PMPrecipio, Inc.: Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancerfinanznachrichten.de - February 6 at 4:00 PMmarketbeat.com - February 6 at 10:00 AMPrecipio’s Q4 cash burn from operations drops below $100K for full quartermsn.com - January 23 at 4:19 PMPrecipio, Inc.: Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterfinanznachrichten.de - January 23 at 4:19 PMPrecipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterfinance.yahoo.com - January 23 at 4:19 PMPrecipio, Inc.: Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japanfinanznachrichten.de - January 17 at 3:59 PMPrecipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japanfinance.yahoo.com - January 17 at 3:59 PMmarketbeat.com - January 17 at 10:32 AMPrecipio Announces Christina Valauri joins the Board of Directorsfinance.yahoo.com - January 2 at 9:25 AMPrecipio, Inc.: Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024finanznachrichten.de - December 15 at 8:20 AMPrecipio Management Shares Thoughts on 2023, and Looks Ahead To 2024finance.yahoo.com - December 14 at 7:47 PMmarketbeat.com - November 14 at 11:10 AMPrecipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022finance.yahoo.com - October 18 at 9:36 AMPrecipio, Inc.: Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023finanznachrichten.de - October 3 at 1:42 PMPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023finance.yahoo.com - October 3 at 1:42 PMPrecipio Continues to Sign New HemeScreen™ Customersfinance.yahoo.com - September 28 at 2:36 PMPrecipio Reduces Product Revenue Result Needed for Cash Flow Breakevenfinance.yahoo.com - September 25 at 3:15 PMPrecipio, Inc.: Precipio Takes Final Step Towards Regaining Nasdaq Compliancefinanznachrichten.de - September 22 at 10:32 AMPrecipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Planfinance.yahoo.com - September 13 at 7:15 PMBroker Revenue Forecasts For Precipio, Inc. (NASDAQ:PRPO) Are Surging Higherfinance.yahoo.com - August 20 at 5:26 PMPrecipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 19 at 6:59 AMPrecipio's Earnings: A Previewbenzinga.com - August 16 at 4:17 PMPrecipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Storyfinance.yahoo.com - August 13 at 6:38 PMPrecipio Announces Q2-2023 Shareholder Update Callfinance.yahoo.com - August 11 at 3:14 AMPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panelfinance.yahoo.com - August 8 at 11:07 AMPrecipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakevenfinance.yahoo.com - August 3 at 1:39 PMEnd in sight for U.S. insider trading case over healthcare leaksinvesting.com - August 1 at 5:31 PMPrecipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023finance.yahoo.com - August 1 at 5:31 PMPrecipio (PRPO) Price Target Decreased by 29.82% to 2.04msn.com - July 6 at 1:54 PMPrecipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technologyfinance.yahoo.com - June 13 at 5:39 PMWhy Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmsn.com - June 8 at 4:34 PMPrecipio Shares Slide Premarket on Sale of Equities >PRPOmarketwatch.com - June 8 at 10:15 AMPrecipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placementfinance.yahoo.com - June 8 at 10:15 AMProjected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projectsfinance.yahoo.com - June 7 at 1:40 PMPrecipio GAAP EPS of -$0.13 misses by $0.02, revenue of $2.82M beats by $0.02Mmsn.com - May 17 at 9:26 PMPrecipio Shares Growth Catalysts For HemeScreenfinance.yahoo.com - May 17 at 4:25 PMPrecipio Announces Q1-2023 Shareholder Update Callfinance.yahoo.com - May 15 at 6:12 PMPrecipio Signs Another HemeScreen™ Customerfinance.yahoo.com - May 4 at 4:53 PMPrecipio Adds Substantial Pathology Customer to its Diagnostic Services Divisionfinance.yahoo.com - May 4 at 4:53 PMPrecipio Granted 180-day Extension From NASDAQ To Regain Compliancefinance.yahoo.com - April 27 at 7:03 PMPrecipio, Inc.: Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combinedfinanznachrichten.de - April 20 at 10:58 AMPrecipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combinedfinance.yahoo.com - April 19 at 1:14 PMPrecipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - April 9 at 12:33 PM Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs. Don't miss out on the "next Ozempic" >>> PRPO Media Mentions By Week PRPO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPO News Sentiment▼0.000.36▲Average Medical News Sentiment PRPO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPO Articles This Week▼10▲PRPO Articles Average Week Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Telesis Bio News Talis Biomedical News Accelerate Diagnostics News Cue Health News Singular Genomics Systems News NuCana News eFFECTOR Therapeutics News Addex Therapeutics News TRxADE HEALTH News Psyence Biomedical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRPO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
